1 row is stored for this page
| Field | Field type | Value |
|---|
| generic | String | Bimatoprost |
| brand | String | Lumigan (glaucoma), Latisse (eyelash growth) |
| structure | File | |
| classes | List of String, delimiter: , | [[:Category:Prostaglandin_analogs|Prostaglandin F2α analog]] • [[:Category:Glaucoma_medications|Glaucoma medication]] • [[:Category:Ocular_hypotensive_agents|Ocular hypotensive agent]] |
| mechanism | String | |
| uses | String | '"`UNIQ--vote-00000D9E-QINU`"', '"`UNIQ--vote-00000D9F-QINU`"', '"`UNIQ--vote-00000DA0-QINU`"' |
| starting_dose | String | 1 drop in the affected eye(s) once daily in the evening (Lumigan); Latisse applied to upper lash line at bedtime |
| preparations | String | 0.01%, 0.03% ophthalmic solution |
| fda_max | String | One drop per eye per day |
| pill_id | Text | |
| routes | List of String, delimiter: , | Topical ophthalmic |
| onset | String | IOP lowering at 4 hours, maximum at 8-12 hours; eyelash effect after 2 months |
| duration | String | 24 hours |
| halflife | String | ~45 minutes (free acid in aqueous humor)'"`UNIQ--ref-00000DA1-QINU`"' |
| bioavailability | String | Topical; minimal systemic absorption'"`UNIQ--ref-00000DA2-QINU`"' |
| pregnancy | String | Limited data; weigh against alternatives.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> |
| legal | String | [[USLegal:Prescription only|Rx-only]] in US |
